Skip to main content

Table 1 Demographic and clinical features of patients with schizophrenia with and without HPRL

From: A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia

Feature

Patients with HPRL, n = 227

Patients without HPRL, n = 219

p-value

Age

49.19 ± 13.19

42.94 ± 13.56

0.031

Male/Female

98/129

123/96

0.006

Dose of antipsychotics into chlorpromazine equivalent

400 (225; 750)

400 (280; 750)

0.074

Duration of the disease

11.0 (4.0; 22.0)

14.0 (8.0; 22.0)

0.041

Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us